Recombinant DNA Advisory Committee- 9/12-13/94 
John Park, University of California, San Francisco 
Virginia Parks, Project Inform 
Nicholas Pelliccione, Schering-Plough Research Institute 
Anne Petruska, The Pink Sheet 
Ramila Philip, Applied Immune Sciences, Inc. 
John Powderly, Georgetown University 
Raj Puri, Food and Drug Administration 
Thomas Reynolds, Targeted Genetics Corporation 
Rex Rhein, Biotechnology Newswatch 
Cindy Richards, Burroughs Wellcome Company 
David Robertson, Vanderbilt University 
Mark Roffman, GenVec, Inc. 
Carolyn Roitsch, Transgene 
Joseph Rokovich, Somatix Therapy Corporation 
Beryl Rosenstein, Johns Hopkins University 
Bruce Schackman, The CTI Group 
Richard Schifreen, Life Technologies, Inc. 
Richard Scotland, Genzyme Corporation 
Steve Shak, Genentech, Inc. 
Terry Sharrer, National Museum of American History 
Tomiko Shimada, Ambience Awareness International, Inc. 
Juliet Singh, Baxter Healthcare Corporation 
William Small, BioConferences International, Inc. 
Steve Sternberg, Private Journalist 
Margi Stuart, Breast Cancer Action 
Franck Sturtz, Progenitor, Inc. 
Nevin Summers, Ingenex, Inc. 
James Symas, St. Elizabeth’s Medical Center 
James Taylor, Taylor Associates 
Paul Tolstoshev, Genetic Therapy, Inc. 
Bruce Trapnell, Genetic Therapy, Inc. 
Joseph Treat, University of Pennsylvania 
Brent Treiger, Applied Immune Sciences, Inc. 
Cynthia Utley, GenVec, Inc. 
Dominick Vacante, Magenta Corporation 
Deborah Vaz, Virus Research Institute 
Alan Venook, University of California, San Francisco 
Samuel Wadsworth, Genzyme Corporation 
Kenneth Walsh, St. Elizabeth’s Medical Center 
Robert Warren, University of California, San Francisco 
Ted Waugh, Foundation on Economic Trends 
Rick Weiss, The Washington Post 
Judi Weissinger, Applied Immune Sciences, Inc. 
Kathleen Whitaker, Quality Biotech 
Lisa White, The Blue Sheet 
Chet Whitley, University of Minnesota 
Recombinant DNA Research, Volume 20 
[15] 
